In the past 30 years, highly specific drugs, known as antibodies, have conquered biopharmaceutical market. addition to monoclonal antibodies (mAbs), antibody fragments are successfully applied. However, recombinant production faces challenges. Process analytical tools for monitoring and controlling processes scarce time-intensive. downstream process (DSP), affinity ligands established primary m...